The Size of the Early Toxicity Testing Market in the Asia Pacific is expected to reach USD 158.51 million by 2025, increasing at a CAGR of 8.4% during the forecast period 2020-2025.
Toxicity is an extent to which a chemical substance or a particular mixture of substances can damage a living organism. During the drug development of the diseases, it has been observed that nearly 28% of the drugs are failing in the later stages of the development causing huge financial losses in the pharmaceutical, food and other industries. So, to avoid this situation, early toxicity testing is implemented in which different types of toxic tests are conducted to remove the toxic substance in the early stages reducing the risk of late-stage failure.
Some of the toxicity tests include carcinogenicity, acute toxicity tests, systemic toxicity, neurotoxicity, and others. All these tests are performed in in-vivo, in-vitro or in-silico techniques. In-vivo toxicity testing is done on the living animals whereas in-vitro technique testing is performed in the laboratories using biochemical assays. In-silico technique testing includes the data analysis on the computer with the help of data mining and modeling tools. These toxicity tests can easily prove to the regulatory bodies that they are extremely safe to human health without causing any adverse effects in the future.
The primary factor driving the Asia-Pacific early toxicity testing market is early toxicity tests that helps the decrease the risk of drug failure in the later stages of the disease. Other factors include increased investment in the R&D of toxic tests to develop new cell assays methods, growing awareness of the regulatory authorities, rise in the demand for early toxicity testing, technology advancements in biotechnology and the favorable government funding in the biotech sector. However, side-effects like skin irritation, lack of awareness about toxicity and stringent government rules will hamper the market growth.
This research report on the Asia Pacific Early Toxicity Testing Market has been segmented and sub-segmented into the following categories
By Technique:
By Assays:
By End-user:
By Country:
On the basis of region, the Asia-Pacific is expected to have the highest CAGR in the coming years owing to the rise in disposable income and growing demographics.
Top Companies dominating the Asia Pacific Early Toxicity Testing Market Profiled in the Report are Covance, Thermo Fisher Scientific, Quest Diagnostics Corporation, Agilent Technologies, Sigma Aldrich, BD Biosciences, Bio-Rad, Gene Logic, Accelrys and Charles River Laboratories.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technique
5.1.1 Introduction
5.1.2 In-vitro
5.1.3 In-vivo
5.1.4 In-Silico
5.1.5 Y-o-Y Growth Analysis, By Technique
5.1.6 Market Attractiveness Analysis, By Technique
5.1.7 Market Share Analysis, By Technique
5.2 Assays
5.2.1 Introduction
5.2.2 Cell-Based ELISA and Western Blots
5.2.3 Enzyme Toxicity Assays
5.2.4 Receptor Binding Assays
5.2.5 Bacterial Toxicity Assays
5.2.6 Tissues Culture Assays
5.2.7 Other Assays
5.2.8 Y-o-Y Growth Analysis, By Assays
5.2.9 Market Attractiveness Analysis, By Assays
5.2.10 Market Share Analysis, By Assays
5.3 End-user
5.3.1 Introduction
5.3.2 Pharmaceutical
5.3.3 Food and Beverages
5.3.4 Chemical Industry
5.3.5 Diagnostics
5.3.6 Cosmetics
5.3.7 Others
5.3.8 Y-o-Y Growth Analysis, By End-user
5.3.9 Market Attractiveness Analysis, By End-user
5.3.10 Market Share Analysis, By End-user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technique
6.1.3.3 By Assays
6.1.3.4 By End-user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technique
6.1.4.3 By Assays
6.1.4.4 By End-user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technique
6.1.5.3 By Assays
6.1.5.4 By End-user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
6.7 Rest of APAC
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Covance
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Thermo Fisher Scientific
8.3 Quest Diagnostics Corporation
8.4 Agilent Technologies
8.5 Sigma Aldrich
8.6 BD Biosciences
8.7 Bio-Rad
8.8 Gene Logic
8.9 Accelrys
8.10 Charles River Laboratories
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
